WEED.TO - Canopy Growth Corporation

Toronto - Toronto Delayed Price. Currency in CAD
56.36
+0.31 (+0.55%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close56.05
Open56.51
Bid56.21 x 0
Ask56.21 x 0
Day's Range56.02 - 57.12
52 Week Range31.81 - 76.68
Volume1,309,043
Avg. Volume2,215,279
Market Cap19.416B
Beta (3Y Monthly)5.28
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
Press Releases
  • PR Newswire2 days ago

    Canopy Growth Provides Update on International Operations and Activities

    SMITHS FALLS, Ontario, June 17, 2019 /PRNewswire/ -- Canopy Growth Corporation ("Canopy Growth" or the "Company") (WEED.TO)(CGC) is pleased to highlight recent developments that are fueling its international progress in emerging medical cannabis and CBD markets. The Company's global three-prong strategy includes a focus on building best-in-class global GMP (Good Manufacturing Practices) infrastructure, advancing clinical research programs and best-in-class education and sales programs through its Spectrum Therapeutics medical division, and launching CBD products where regulatory environments allow.

  • Canopy Growth provides update on international operations and activities
    CNW Group2 days ago

    Canopy Growth provides update on international operations and activities

    SMITHS FALLS, ON , June 17, 2019 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (WEED.TO)(CGC) is pleased to highlight recent developments that are fueling its international progress in emerging medical cannabis and CBD markets. The Company's global three-prong strategy includes a focus on building best-in-class global GMP (Good Manufacturing Practices) infrastructure, advancing clinical research programs and best-in-class education and sales programs through its Spectrum Therapeutics medical division, and launching CBD products where regulatory environments allow.

  • Canopy Growth and Acreage Holdings Remind Shareholders to Vote FOR Canopy Growth's Plan to Acquire Acreage
    PR Newswire5 days ago

    Canopy Growth and Acreage Holdings Remind Shareholders to Vote FOR Canopy Growth's Plan to Acquire Acreage

    Canopy Growth's brands, technology and know-how is anticipated to provide Acreage with a significant advantage in an increasingly competitive U.S. market and fuel Acreage's growth. Acreage shareholders will benefit from Acreage's ability to achieve its growth strategy with an anticipated reduced cost of capital based on Canopy Growth affiliation. Canopy Growth shareholders will benefit from accelerated and turnkey access to the U.S. cannabis market upon the closing of the Transaction.

  • CNW Group9 days ago

    /R E P E A T -- Canopy Growth to Announce Fourth Quarter and Fiscal Year 2019 Financial Results/

    /R E P E A T -- Canopy Growth to Announce Fourth Quarter and Fiscal Year 2019 Financial Results/

  • CNW Group12 days ago

    Canopy Growth to Announce Fourth Quarter and Fiscal Year 2019 Financial Results

    Canopy Growth to Announce Fourth Quarter and Fiscal Year 2019 Financial Results

  • PR Newswire13 days ago

    Spectrum Therapeutics Provides Update on Its Global Clinical Research Program and Unveils Pharmacovigilance

    SMITHS FALLS, Ontario, June 6, 2019 /PRNewswire/ -- Spectrum Therapeutics ("Spectrum"), the medical division of Canopy Growth Corporation (WEED.TO) (CGC) (the "Company" or "Canopy Growth") is pleased to share an update on its efforts to develop and commercialize validated cannabis medicines through clinical trials. With a highly experienced scientific team and the resources needed to conduct robust clinical trials, Spectrum Therapeutics is pursuing research to introduce products for the therapeutic areas of pain, mood and sleep and to gain access to new markets independent of medical cannabis laws.

  • PR Newswire14 days ago

    Spectrum Therapeutics provides update on its global clinical research program and unveils pharmacovigilance program

    SMITHS FALLS, ON, June 5, 2019 /PRNewswire/ - Spectrum Therapeutics ("Spectrum"), the medical division of Canopy Growth Corporation (WEED.TO) (CGC) (the "Company" or "Canopy Growth") is pleased to share an update on its efforts to develop and commercialize validated cannabis medicines through clinical trials. With a highly experienced scientific team and the resources needed to conduct robust clinical trials, Spectrum Therapeutics is pursuing research to introduce products for the therapeutic areas of pain, mood and sleep and to gain access to new markets independent of medical cannabis laws.

  • /R E P E A T -- Meet Your New Neighbour: Tweed! Tweed Brings Its Unique Brand of Cannabis and Conversation to Saskatoon, SK/
    CNW Group20 days ago

    /R E P E A T -- Meet Your New Neighbour: Tweed! Tweed Brings Its Unique Brand of Cannabis and Conversation to Saskatoon, SK/

    SASKATOON , May 29, 2019 /CNW/ - Tweed, Canada's top cannabis producer, opened its first store in Saskatoon on May 17th and is excited to host the grand opening this Friday, May 31st . Recreational cannabis is new to many consumers, but we've been pioneers as a medical producer for years.

  • Meet Your New Neighbour: Tweed! Tweed Brings Its Unique Brand of Cannabis and Conversation to Saskatoon, SK
    CNW Group20 days ago

    Meet Your New Neighbour: Tweed! Tweed Brings Its Unique Brand of Cannabis and Conversation to Saskatoon, SK

    SASKATOON , May 29, 2019 /CNW/ - Tweed, Canada's top cannabis producer, opened its first store in Saskatoon on May 17th and is excited to host the grand opening this Friday, May 31st . Recreational cannabis is new to many consumers, but we've been pioneers as a medical producer for years.

  • CNW Group22 days ago

    Canopy Growth collaborates with Parent Action on Drugs to launch digital cannabis education tools

    SMITHS FALLS, ON and TORONTO , May 28, 2019 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (WEED.TO) (CGC) is pleased to announce the next phase in its partnership with Parent Action on Drugs ("PAD") and Canadian Students for Sensible Drug Policy ("CSSDP") which will see PAD launch two new digital tools to help youth along with their parents, adult caregivers, and influencers, on how to make responsible decisions about cannabis use. This tool helps parents structure conversations with their pre-teens about cannabis to inform and prevent early use, associated with a number of negative short and long-term outcomes. Through activities like charades, quiz questions, and "what would you do?" scenarios, chatbot users learn age-appropriate evidence-based information about cannabis, its effects, the law, risks to youth during brain development, and reasons youth consume or not.

  • PR Newswire22 days ago

    Canopy Growth subsidiary and Canopy Rivers portfolio company Vert Mirabel now fully licensed by Health Canada

    MIRABEL, QC, May 28, 2019 /PRNewswire/ - Les Serres Vert Cannabis Inc. ("Vert Mirabel"), a subsidiary of Canopy Growth Corporation (WEED.TO) (CGC) ("Canopy Growth") and a portfolio company of Canopy Rivers Inc. (RIV.V) (CNPOF) ("Canopy Rivers") has received its final cultivation licence from Health Canada. All 700,000 sq. ft. of operating space at Vert Mirabel is now licensed for cannabis production. Vert Mirabel was established in December 2017 between Canopy Growth, Canopy Rivers, and Les Serres Stéphane Bertrand ("Bertrand"). "We are thrilled that the operational infrastructure at Vert Mirabel is now fully online with over 500,000 sq. ft. already in production," said Olivier Dufourmantelle, Chief Operating Officer, Canopy Rivers.

  • Canopy Growth and Acreage Holdings Announce Filing of Management Information Circulars Related to Canopy's Plan to Acquire Acreage
    CNW Group27 days ago

    Canopy Growth and Acreage Holdings Announce Filing of Management Information Circulars Related to Canopy's Plan to Acquire Acreage

    Canopy Growth's brands, technology and know-how is anticipated to provide Acreage with a significant and immediate advantage in an increasingly competitive U.S. market and fuel Acreage's growth. Acreage shareholders to receive immediate upfront cash consideration, on an as-converted to Subordinate Voting Share basis, of approximately US$2.51 - $2.63 per share upon the initial implementation of the Transaction. On completion of the Transaction, each Acreage share will be converted into 0.5818 of a common share of Canopy Growth, subject to any required adjustments.

  • /R E P E A T -- Meet Your New Neighbour: It's Tweed! Tweed Brings Its Unique Brand of Cannabis and Conversation to Meadow Lake, SK/
    CNW Group27 days ago

    /R E P E A T -- Meet Your New Neighbour: It's Tweed! Tweed Brings Its Unique Brand of Cannabis and Conversation to Meadow Lake, SK/

    Tweed, Canada's top cannabis producer, is excited to announce the May 23rd grand opening of their Meadow Lake retail location with a celebration of fun, education and most importantly, community love! Legal cannabis is new to many consumers but we've been cutting our teeth as a medical producer for years so we can help suggest strains and educate on the different ways to consume cannabis.

  • Meet Your New Neighbour: It's Tweed! Tweed Brings Its Unique Brand of Cannabis and Conversation to Meadow Lake, SK
    CNW Group28 days ago

    Meet Your New Neighbour: It's Tweed! Tweed Brings Its Unique Brand of Cannabis and Conversation to Meadow Lake, SK

    Tweed, Canada's top cannabis producer, is excited to announce the May 23rd grand opening of their Meadow Lake retail location with a celebration of fun, education and most importantly, community love! Legal cannabis is new to many consumers but we've been cutting our teeth as a medical producer for years so we can help suggest strains and educate on the different ways to consume cannabis.

  • PR Newswire28 days ago

    Canopy Growth acquires established skincare and well-being company This Works®

    SMITHS FALLS, ON and LONDON, May 22, 2019 /PRNewswire/ - Canopy Growth Corporation (WEED.TO) (CGC) (the "Company" or "Canopy Growth") has finalized an all-cash transaction to acquire This Works for a purchase price of £43 million (CDN $73.8 million). Founded in 2004, This Works has cemented itself as a global leader in natural skincare and sleep solutions with a devout customer base spanning 35 countries. Headquartered in London, England, This Works offers a range of high-quality natural skincare and sleep solution products that have rewarded the company with a loyal following of customers purchasing their best-known products including deep sleep pillow spray, morning expert hyaluronic serum, and skin deep dry leg oil.

  • Canopy Rivers Portfolio Company Agripharm Awarded Outdoor Cultivation Licence
    CNW Group29 days ago

    Canopy Rivers Portfolio Company Agripharm Awarded Outdoor Cultivation Licence

    TORONTO , May 21, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) is pleased to share that its portfolio company, Agripharm Corp. ("Agripharm"), has received its outdoor cultivation license from Health Canada. "We are pleased to see Agripharm diversify its operations and increase its growing capacity with the grant of this outdoor cultivation licence," said Oliver Dufourmantelle, Chief Operating Officer of Canopy Rivers. Founded in 2013, Agripharm is home to both the first cannabis production facility built from the ground up and the first supercritical CO2 extraction lab in Canada .